Developer docs
API playgroundTry for free, no card

Search company profiles

Alithia Life Sciences

Full company profile

uuid0026zr3

Namestring
Alithia Life Sciences
Legal namestring
Alithia Life Sciences
Company typeenum
Private
Founded yearint
2021
Descriptiontext

Alithia Life Sciences is a privately-held, Australian-owned full-service Contract Research Organisation headquartered in Melbourne and operating across Australia, New Zealand, and selected global markets via a partner network. The company provides end-to-end clinical trial services to biotech, pharmaceutical, MedTech, digital health, and investor clients, structured around three integrated offerings: Strategy & Advisory (regulatory strategy, KOL engagement, indicative cost/timeline estimates), Clinical & Operational Excellence (trial design, site strategy, project management, monitoring, site management, vendor oversight), and Local Directorship (enabling international sponsors to conduct trials in Australia with local governance). Its core technology stack is operational rather than productized — clinical research operations and project management for end-to-end trial delivery — and it does not disclose proprietary software products.

The company monetizes through professional services contracts, with pricing quote-based and customized per project scope, therapeutic area, phase, and complexity. Its go-to-market is enterprise field sales, with the Founder/Director and CCO personally engaging clients, supplemented by industry events (BIO 2026, RESI San Diego 2026, ARCS Australia), webinars, LinkedIn presence, and a 20+ partner referral network spanning AusBiotech, ARCS, BioMelbourne Network, CCRM Australia, and global CROs. Key customer testimonials include Murdoch Children's Research Institute, Avecho Biotechnology, and PharmAust. Alithia's structural differentiator is leveraging Australia's regulatory environment — no IND requirement, GMP exemption for FIH studies, 2-3 month start-up timelines, up to 43.5% R&D cash tax incentive, and FDA/EMA-accepted data — packaged through its Local Directorship offering. The firm is founder-led by A/Prof Tina Soulis, supported by a CCO with IQVIA/Parexel/Medtronic background and a Director of Clinical Operations with 28 years of industry experience.

Short descriptiontext

Alithia Life Sciences is a privately-held, Australian-owned boutique CRO headquartered in Melbourne that provides end-to-end clinical trial services — strategy, operational delivery, and local directorship — to biotech, pharma, MedTech, digital health, and investor clients across Australia, New Zealand, and global markets.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersMelbourne, Australia
HQ citystring
Melbourne
HQ countrystring
Australia
HQ regionstring
Oceania
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical trial services, contract research organization, biotech clinical development, regulatory strategy services, clinical operations management
Industry4 codes
PRIMARYHLAGAAAA
Clinical CROs (Phase I–IV)
SECONDARYHLAGAAAI
Patient Recruitment, Site Feasibility & Trial Enablement CROs
SECONDARYHLAGACAC
Clinical Site Start-Up & Activation (Regulatory/Ethics/Contracts)
SECONDARYHLAGAKAA
Regulatory Strategy & Global Submissions (IND/CTA/NDA/BLA/MAA)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
NAICS code2 codes
  • Scientific Research and Development Services5417
  • Other Scientific and Technical Consulting Services54169
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Clinical Research Services
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1CRO Services - Clinical Trial Management
TypeProfessional Services
Description

Full-service Contract Research Organization providing clinical development program support, trial design, site strategy, project management, monitoring, site management, and vendor oversight. Revenue generated through service contracts for biotech, pharma, MedTech and digital health clients.

alithialifesciences.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Alithia Life Sciences is a proudly Australian-owned, full-service Contract Research Organization (CRO) that delivers end-to-end clinical trial services for biotech, pharma, MedTech, digital health sponsors, and investors. The company provides three integrated offerings: Strategy & Advisory (regulatory and clinical development strategy, KOL engagement, cost and timeline scenarios, Clinical Trial Liaison services); Clinical & Operational Excellence (trial design, site strategy, project management, monitoring, site management, vendor oversight); and Local Directorship (regulatory governance for international sponsors running trials in Australia/NZ).

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Rapid start-up: 2-3 months average from protocol to first patient
+2 more records
Product overview1 text field

Alithia Life Sciences is an Australian-owned full-service Contract Research Organisation (CRO) offering a unified service portfolio rather than discrete software products. The company provides end-to-end clinical development services structured around three core integrated offerings: Strategy & Advisory (providing indicative estimates, timelines, cost scenarios, regulatory strategy, KOL engagement, and Clinical Trial Liaison services); Clinical & Operational Excellence (covering clinical development program optimization, trial design and site strategy, project management, operational delivery including monitoring and site management services, and vendor oversight); and Local Directorship (enabling international sponsors to conduct clinical trials in Australia with local regulatory compliance and governance). Services span multiple therapeutic areas (FIH and Healthy Volunteer studies, Neurology, Devices, Endocrinology, Oncology, Women's health, Ophthalmology, Gastroenterology, Cardiovascular, Respiratory, Rare and Paediatric diseases, Vaccines) and support various investigational products including Drugs, Devices, Cell and Gene therapies, and Combination therapy trials.

Product and service3 records
1Strategy & Advisory
CategoryClinical Research Services
Description

Strategy and Advisory services that turn clinical development complexity into clear direction through indicative cost and timeline estimates for planning, investor, and board discussions, regulatory and clinical development strategy, Key Opinion Leader (KOL) engagement, and Clinical Trial Liaison services acting as the client's local support person. Designed for biotech, pharma, MedTech, digital health sponsors, and investors needing strategic clarity before and during trial execution.

2Clinical & Operational Excellence
CategoryClinical Research Services
Description

Clinical and operational delivery service covering clinical development program optimization, trial design, site strategy, project management, monitoring and site management services, and vendor oversight with operational scale-up. Designed for biotech, pharma, MedTech, and digital health sponsors executing trials across therapeutic areas including FIH studies, Neurology, Devices, Endocrinology, Oncology, Women's health, Ophthalmology, Gastroenterology, Cardiovascular, Respiratory, Rare and Paediatric diseases, and Vaccines.

3Local Directorship
CategoryClinical Research Services
Description

Local Directorship and governance service enabling international biotech, pharma, and MedTech sponsors to conduct clinical trials in Australia while meeting regulatory requirements. Provides clear governance, experienced local oversight, and Australian in-country representation for sponsors lacking a domestic presence.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership20 partners
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partner listed in Alithia's industry affiliations and partners section. PureCDM appears to be a clinical development management partner.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partner listed in Alithia's industry affiliations and partners section.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partner listed in Alithia's industry affiliations and partners section.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partner listed in Alithia's industry affiliations and partners section. CCRM focuses on cell and gene therapy.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Peak biotechnology industry body in Australia. Alithia maintains affiliation for industry networking and advocacy.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Association for Clinical Research Site organizations. Alithia affiliated for industry standards and networking.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Melbourne-based life sciences industry network. Alithia participates in events and collaborations.

8A Fortiori Development
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partner listed in Alithia's industry affiliations and partners section.

alithialifesciences.com
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Clinical trials network focused on movement disorders research.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Foundation fighting Motor Neurone Disease. Alithia affiliated for research collaboration.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Clinical trials organization partner listed in affiliations.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

New South Wales biotechnology industry organization.

13Resolutum Global
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Global CRO partner for international trial expansion.

alithialifesciences.com
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Environmental and sustainability consulting partner.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Pharmaceutical logistics and distribution partner.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Academic research institution partner for clinical trials.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Clinical research network focused on Niemann-Pick disease.

18SmartCRC
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Clinical research coordination partner.

alithialifesciences.com
19EBPRG
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Evidence-based practice research group partner.

alithialifesciences.com
20MaH-CTS
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Clinical trials support organization.

alithialifesciences.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Largest Australian-owned boutique CRO, also marketed around Australia's regulatory and tax advantages for biotech sponsors. Direct head-to-head competitor for the same international biotech and Phase I/II inbound study work Alithia targets.

TypeBroad incumbent
Description

Global CRO offering Phase I-IV clinical development services. Comparable broad-service incumbent that wins large multi-region programs Alithia can only access via partner hand-offs.

TypeDirect peer
Description

Adelaide-based Australian CRO specializing in early-phase clinical trials, including FIH and healthy-volunteer studies. Comparable boutique-scale CRO leveraging Australia's regulatory environment for biotech sponsors.

TypeEmerging player
Description

Mid-sized global CRO with Asia-Pacific presence targeting similar biotech and specialty pharma sponsors. Comparable size tier to Alithia's aspiration scale with broader geographic footprint.

TypeBroad incumbent
Description

Global biopharmaceutical solutions organization with clinical and commercial services. Competes for biotech and pharma outsourcing dollars across the same functional areas Alithia serves.

TypeBroad incumbent
Description

Largest global CRO/commercial life sciences services provider. Alithia's CCO previously worked at IQVIA; competes for enterprise pharma contracts that Alithia aspires to capture as it scales.

TypeBroad incumbent
Description

Top-tier global full-service CRO. Alithia's CCO previously held a role at Parexel; represents the global full-service delivery standard Alithia is positioning against at the boutique level.

TypeBroad incumbent
Description

Global CRO and preclinical/research services provider. Larger-scale incumbent offering end-to-end development services that overlap with Alithia's biotech and pharma support offerings.

TypeDirect peer
Description

Australian early-phase clinical trial and FIH specialist with clinical pharmacology units. Overlaps directly with Alithia's stated FIH, healthy-volunteer, and Phase I capabilities.

TypeRegional player
Description

Asia-Pacific focused mid-to-large CRO headquartered in Australia. Serves similar biotech sponsor base across the region but with substantially greater scale, full-service Phase I-IV delivery, and broader geographic reach.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Alithia Life Sciences

Clinical Research Servicesalithialifesciences.com

Alithia Life Sciences is a privately-held, Australian-owned boutique CRO headquartered in Melbourne that provides end-to-end clinical trial services — strategy, operational delivery, and local directorship — to biotech, pharma, MedTech, digital health, and investor clients across Australia, New Zealand, and global markets.

What Alithia Life Sciences does

Alithia Life Sciences is a privately-held, Australian-owned full-service Contract Research Organisation headquartered in Melbourne and operating across Australia, New Zealand, and selected global markets via a partner network. The company provides end-to-end clinical trial services to biotech, pharmaceutical, MedTech, digital health, and investor clients, structured around three integrated offerings: Strategy & Advisory (regulatory strategy, KOL engagement, indicative cost/timeline estimates), Clinical & Operational Excellence (trial design, site strategy, project management, monitoring, site management, vendor oversight), and Local Directorship (enabling international sponsors to conduct trials in Australia with local governance). Its core technology stack is operational rather than productized — clinical research operations and project management for end-to-end trial delivery — and it does not disclose proprietary software products.

The company monetizes through professional services contracts, with pricing quote-based and customized per project scope, therapeutic area, phase, and complexity. Its go-to-market is enterprise field sales, with the Founder/Director and CCO personally engaging clients, supplemented by industry events (BIO 2026, RESI San Diego 2026, ARCS Australia), webinars, LinkedIn presence, and a 20+ partner referral network spanning AusBiotech, ARCS, BioMelbourne Network, CCRM Australia, and global CROs. Key customer testimonials include Murdoch Children's Research Institute, Avecho Biotechnology, and PharmAust. Alithia's structural differentiator is leveraging Australia's regulatory environment — no IND requirement, GMP exemption for FIH studies, 2-3 month start-up timelines, up to 43.5% R&D cash tax incentive, and FDA/EMA-accepted data — packaged through its Local Directorship offering. The firm is founder-led by A/Prof Tina Soulis, supported by a CCO with IQVIA/Parexel/Medtronic background and a Director of Clinical Operations with 28 years of industry experience.

Alithia Life Sciences firmographics

Firmographics
Name
Alithia Life Sciences
Legal name
Alithia Life Sciences
Website
https://alithialifesciences.com
Company type
Private
Founded year
2021
Operating status
Operating
Headcount range
11–50 employees
Short description
Alithia Life Sciences is a privately-held, Australian-owned boutique CRO headquartered in Melbourne that provides end-to-end clinical trial services — strategy, operational delivery, and local directorship — to biotech, pharma, MedTech, digital health, and investor clients across Australia, New Zealand, and global markets.
Ownership category
akta.pro rank

Alithia Life Sciences industry classification

Industry
Product category
Clinical Research Services
NAICS
Scientific Research and Development Services (5417), Other Scientific and Technical Consulting Services (54169)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGAAAA
Clinical CROs (Phase I–IV)
SECONDARYHLAGAAAI
Patient Recruitment, Site Feasibility & Trial Enablement CROs
SECONDARYHLAGACAC
Clinical Site Start-Up & Activation (Regulatory/Ethics/Contracts)
SECONDARYHLAGAKAA
Regulatory Strategy & Global Submissions (IND/CTA/NDA/BLA/MAA)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)

Keywords

  • Clinical trial services
  • Contract research organization
  • Biotech clinical development
  • Regulatory strategy services
  • Clinical operations management

Where Alithia Life Sciences is headquartered

Location

Headquarters

HQ city
Melbourne
HQ country
Australia
HQ region
Oceania

Offices1 record

Markets served

Alithia Life Sciences business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

  1. CRO Services - Clinical Trial Management: Full-service Contract Research Organization providing clinical development program support, trial design, site strategy, project management, monitoring, site management, and vendor oversight. Revenue generated through service contracts for biotech, pharma, MedTech and digital health clients.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Alithia Life Sciences product offering

Product offering

Core offering

Alithia Life Sciences is a proudly Australian-owned, full-service Contract Research Organization (CRO) that delivers end-to-end clinical trial services for biotech, pharma, MedTech, digital health sponsors, and investors. The company provides three integrated offerings: Strategy & Advisory (regulatory and clinical development strategy, KOL engagement, cost and timeline scenarios, Clinical Trial Liaison services); Clinical & Operational Excellence (trial design, site strategy, project management, monitoring, site management, vendor oversight); and Local Directorship (regulatory governance for international sponsors running trials in Australia/NZ).

Product overview

Alithia Life Sciences is an Australian-owned full-service Contract Research Organisation (CRO) offering a unified service portfolio rather than discrete software products. The company provides end-to-end clinical development services structured around three core integrated offerings: Strategy & Advisory (providing indicative estimates, timelines, cost scenarios, regulatory strategy, KOL engagement, and Clinical Trial Liaison services); Clinical & Operational Excellence (covering clinical development program optimization, trial design and site strategy, project management, operational delivery including monitoring and site management services, and vendor oversight); and Local Directorship (enabling international sponsors to conduct clinical trials in Australia with local regulatory compliance and governance). Services span multiple therapeutic areas (FIH and Healthy Volunteer studies, Neurology, Devices, Endocrinology, Oncology, Women's health, Ophthalmology, Gastroenterology, Cardiovascular, Respiratory, Rare and Paediatric diseases, Vaccines) and support various investigational products including Drugs, Devices, Cell and Gene therapies, and Combination therapy trials.

Differentiator

Problem solved

Functional benefit

Products and services

  • Strategy & Advisory Strategy and Advisory services that turn clinical development complexity into clear direction through indicative cost and timeline estimates for planning, investor, and board discussions, regulatory and clinical development strategy, Key Opinion Leader (KOL) engagement, and Clinical Trial Liaison services acting as the client's local support person. Designed for biotech, pharma, MedTech, digital health sponsors, and investors needing strategic clarity before and during trial execution.
  • Clinical & Operational Excellence Clinical and operational delivery service covering clinical development program optimization, trial design, site strategy, project management, monitoring and site management services, and vendor oversight with operational scale-up. Designed for biotech, pharma, MedTech, and digital health sponsors executing trials across therapeutic areas including FIH studies, Neurology, Devices, Endocrinology, Oncology, Women's health, Ophthalmology, Gastroenterology, Cardiovascular, Respiratory, Rare and Paediatric diseases, and Vaccines.
  • Local Directorship Local Directorship and governance service enabling international biotech, pharma, and MedTech sponsors to conduct clinical trials in Australia while meeting regulatory requirements. Provides clear governance, experienced local oversight, and Australian in-country representation for sponsors lacking a domestic presence.

Quantifiable outcome

  • Rapid start-up: 2-3 months average from protocol to first patient
  • +2 more outcomes

Companies that use Alithia Life Sciences

Customer profile

Named customers3 records

Segments4 records

Ideal customer profiles4 records

Alithia Life Sciences technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Alithia Life Sciences partnerships and signals

Strategic signal

Partnerships

20 partnerships are on record, tiered minor.

  • PureCDMminorStrategic or Co-development PartnerPartner listed in Alithia's industry affiliations and partners section. PureCDM appears to be a clinical development management partner.
  • Ichor Life SciencesminorStrategic or Co-development PartnerPartner listed in Alithia's industry affiliations and partners section.
  • Facet Life SciencesminorStrategic or Co-development PartnerPartner listed in Alithia's industry affiliations and partners section.
  • CCRM AustraliaminorStrategic or Co-development PartnerPartner listed in Alithia's industry affiliations and partners section. CCRM focuses on cell and gene therapy.
  • AusBiotechminorStrategic or Co-development PartnerPeak biotechnology industry body in Australia. Alithia maintains affiliation for industry networking and advocacy.
  • ARCS AustraliaminorStrategic or Co-development PartnerAssociation for Clinical Research Site organizations. Alithia affiliated for industry standards and networking.
  • BioMelbourne NetworkminorStrategic or Co-development PartnerMelbourne-based life sciences industry network. Alithia participates in events and collaborations.
  • A Fortiori DevelopmentminorStrategic or Co-development PartnerPartner listed in Alithia's industry affiliations and partners section.
  • Movement Disorders Society of Australia and New Zealand Clinical Trials NetworkminorStrategic or Co-development PartnerClinical trials network focused on movement disorders research.
  • FightMNDminorStrategic or Co-development PartnerFoundation fighting Motor Neurone Disease. Alithia affiliated for research collaboration.
  • CeruleaminorStrategic or Co-development PartnerClinical trials organization partner listed in affiliations.
  • NSW BiominorStrategic or Co-development PartnerNew South Wales biotechnology industry organization.
  • Resolutum GlobalminorChannel Partner/ Reseller/ DistributorGlobal CRO partner for international trial expansion.
  • ScendeaminorStrategic or Co-development PartnerEnvironmental and sustainability consulting partner.
  • Central Pharmacy LogisticsminorStrategic or Co-development PartnerPharmaceutical logistics and distribution partner.
  • University of Sunshine CoastminorStrategic or Co-development PartnerAcademic research institution partner for clinical trials.
  • Nieman-PickCminorStrategic or Co-development PartnerClinical research network focused on Niemann-Pick disease.
  • SmartCRCminorStrategic or Co-development PartnerClinical research coordination partner.
  • EBPRGminorStrategic or Co-development PartnerEvidence-based practice research group partner.
  • MaH-CTSminorStrategic or Co-development PartnerClinical trials support organization.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Alithia Life Sciences competitors and assessment

Company assessment

Direct peers

  • Avance Clinical: Largest Australian-owned boutique CRO, also marketed around Australia's regulatory and tax advantages for biotech sponsors. Direct head-to-head competitor for the same international biotech and Phase I/II inbound study work Alithia targets.
  • CMAX Clinical Research: Adelaide-based Australian CRO specializing in early-phase clinical trials, including FIH and healthy-volunteer studies. Comparable boutique-scale CRO leveraging Australia's regulatory environment for biotech sponsors.
  • Nucleus Network: Australian early-phase clinical trial and FIH specialist with clinical pharmacology units. Overlaps directly with Alithia's stated FIH, healthy-volunteer, and Phase I capabilities.

Broad incumbents

  • ICON plc: Global CRO offering Phase I-IV clinical development services. Comparable broad-service incumbent that wins large multi-region programs Alithia can only access via partner hand-offs.
  • Syneos Health: Global biopharmaceutical solutions organization with clinical and commercial services. Competes for biotech and pharma outsourcing dollars across the same functional areas Alithia serves.
  • IQVIA: Largest global CRO/commercial life sciences services provider. Alithia's CCO previously worked at IQVIA; competes for enterprise pharma contracts that Alithia aspires to capture as it scales.
  • Parexel: Top-tier global full-service CRO. Alithia's CCO previously held a role at Parexel; represents the global full-service delivery standard Alithia is positioning against at the boutique level.
  • Charles River Laboratories: Global CRO and preclinical/research services provider. Larger-scale incumbent offering end-to-end development services that overlap with Alithia's biotech and pharma support offerings.

Emerging players

  • Linical: Mid-sized global CRO with Asia-Pacific presence targeting similar biotech and specialty pharma sponsors. Comparable size tier to Alithia's aspiration scale with broader geographic footprint.

Regional players

  • Novotech: Asia-Pacific focused mid-to-large CRO headquartered in Australia. Serves similar biotech sponsor base across the region but with substantially greater scale, full-service Phase I-IV delivery, and broader geographic reach.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Alithia Life Sciences social profiles

Digital presence

Alithia Life Sciences financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Alithia Life Sciences leadership team

Management profile

Number of profiles

Profiles3 records

Alithia Life Sciences funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Alithia Life Sciences M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Alithia Life Sciences

What does Alithia Life Sciences do?

Alithia Life Sciences is a proudly Australian-owned, full-service Contract Research Organization (CRO) that delivers end-to-end clinical trial services for biotech, pharma, MedTech, digital health sponsors, and investors. The company provides three integrated offerings: Strategy & Advisory (regulatory and clinical development strategy, KOL engagement, cost and timeline scenarios, Clinical Trial Liaison services); Clinical & Operational Excellence (trial design, site strategy, project management, monitoring, site management, vendor oversight); and Local Directorship (regulatory governance for international sponsors running trials in Australia/NZ).

Is Alithia Life Sciences a public or private company?

Alithia Life Sciences is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Alithia Life Sciences founded?

Alithia Life Sciences was founded in 2021. It employs 11 to 50 people.

Where is Alithia Life Sciences based?

Alithia Life Sciences is headquartered in Melbourne, Australia, in the Oceania region.

How does Alithia Life Sciences make money?

One revenue line is on record: CRO Services - Clinical Trial Management.

Who are Alithia Life Sciences's main competitors?

Direct peers on record are Avance Clinical, CMAX Clinical Research and Nucleus Network. Broad incumbents are ICON plc, Syneos Health, IQVIA, Parexel and Charles River Laboratories. Linical is listed as an emerging player. Novotech is listed as a regional player.

Does Alithia Life Sciences have an API?

No public API is recorded for Alithia Life Sciences.

What industry is Alithia Life Sciences in?

Alithia Life Sciences's product category is Clinical Research Services. Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV), with a secondary code of HLAGAAAI, Patient Recruitment, Site Feasibility & Trial Enablement CROs. Its NAICS code is 5417 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals